Oncodesign competitors

Oncodesign Competitors include Athersys, Otonomy, Kiniksa Pharmaceuticals and Biogen.
Add company...
Oncodesign
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Founding Date
Founding Date
1995
Founding Date
1995
Founding Date
2008
Founding Date
2015
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dijon, FR HQ
Locations
Cleveland, US HQ
Canton, US
Locations
San Diego, US HQ
Locations
Lexington, US HQ
Hamilton, BM
San Diego, US
Locations
Cambridge, US HQ
Employees
Employees
1021% decrease
Employees
60
Employees
139
Employees
41
Employees
7,3001% decrease
Valuation ($)
Valuation ($)
91.4 m
Valuation ($)
277.2 m
Valuation ($)
75 m
Valuation ($)
935.7 m
Valuation ($)
65.9 b
Facebook likes
Facebook likes
N/A
Facebook likes
475
Facebook likes
1.1 k
Facebook likes
N/A
Facebook likes
3.1 k
Twitter followers
Twitter followers
N/A
Twitter followers
953
Twitter followers
267
Twitter followers
N/A
Twitter followers
19.4 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$3.7m (FY, 2017)
Revenue (est.)
$1.2m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
($90.1m) (FY, 2017)
Net income
N/A
Net income
$3.7b (FY, 2016)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
88 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 4.7m
Total funding raised
$ 9m
Total funding raised
$ 153.4m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Athersys
HQ
Cleveland, US
Employees
60

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Otonomy
HQ
San Diego, US
Employees
139

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Kiniksa Pharmaceuticals
HQ
Lexington, US
Employees
41

Kiniksa Pharmaceuticals focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

View company
Biogen
HQ
Cambridge, US
Employees
7,300↓ 1% decrease

Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.

View company